Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Health Affairs: U.S. spends 4x more than Canada on payor interaction

In contrast to Canada, U.S. physician practices spend nearly four times more interacting with payors, according to researchers in the August edition of Health Affairs.

Webinar: Successful HIEs disseminate funds in disciplined manner

Successful health information exchanges (HIEs) tend to charge per subscription, rather than per usage, which could potentially discourage data sharing, according to a report released from National eHealth Collaborative (NeHC),  which includes case studies from 12 sustainable HIEs.

Hospitals: Medicare auditing unfair but effective

Most hospitals feel the U.S. governments healthcare agencies treat them unfairly when auditing their Medicare claims but, by an even wider margin, they admit that the auditing process does what its supposed to do. Those are among the standout conclusions of a survey by Ivans, a healthcare consulting firm based in Stamford, Conn.

Quality Congress: Onsite clinics help drive population health

BOSTONThe concept of providers engaging the employers in a discussion around changing how care is delivered is going to spread rapidly for those providers who are going to survive, Ashok N. Rai, MD, president and CEO at Prevea Health, a health network with 28 health centers servicing northeast Wisconsin, said in an interview, during the 9th Annual Health Care Quality Congress presented by the World Congress.

IOM: Nationwide surveillance programs could help curb chronic disease

While surveillance programs focused on chronic diseases are effective, these types of systems currently do not exist and do not operate in a coordinated manner to integrate and report current chronic disease data across the U.S. Thus, the National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention turned to the Institute of Medicine (IOM) to create a framework for a national surveillance system, and the institute concluded that surveillance systems can improve the monitoring and tracking of chronic diseases.

Commonwealth Fund: Better infrastructure needed for ACOs

Relating to accountable care organization (ACO) initiatives, providers do not currently have the infrastructure required to take on and manage risk successfully, though some payors are providing infrastructure and other support to providers, according to a July report published by the Commonwealth Fund.

JACC: Combining CV outcomes demonstrates better hospital quality

Hospitals that consistently demonstrate superior performance in both acute MI (AMI) and heart failure (HF) measures have a significantly lower risk-adjusted mortality rate than hospitals that achieve a superior performance in only one or neither measure, according to a study published in the Aug. 2 issue of the Journal of the American College of Cardiology. The results suggest that a combined set of cardiovascular disease measures may more accurately reflect the quality of care in a hospital and optimize patient outcomes.

GE Healthcare acquires event reporting tech

GE Healthcare Performance Solutions has acquired the Medical Event Reporting System (MERS) patient safety evaluation technology from Netherlands-based MERS International to assist capturing, reporting and analyzing safety events and near misses.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.